# US 2012/0083734 A1 · Balloon catheter comprising pressure sensitive microparticles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083734 A1
- Document ID: US20120083734A1
- Status: Published application
- Kind: A1
- Application number: 13/320,734
- Filed: 2010-05-17
- Published: 2012-04-05
- Earliest claimed: 2009-05-18
- Assignees: Encapson B.V.
- Inventors: Lee Ayres; Dennis Manuel Vriezema; Johannes Hendrikus Leonardus Hanssen; Johannes Antonius Opsteen
- Web page: https://patentgrep.com/patent/US20120083734A1

## CPC

- A61L 29/14: Materials characterised by their function or physical properties {, e.g. lubricating compositions}
- A61L 29/085: {Macromolecular materials}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 2300/606: Coatings
- A61L 2300/622: Microcapsules
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The invention provides a solution to the above mentioned problem in that it provides a catheter balloon comprising a flexible coating on its outer surface wherein a plurality of microparticles are contained wherein said coating comprises a material selected from the group consisting of poly(N-vinyl-pirrolidone, poly(N-vinyl-pirrolidone-co-butylacrylate), poly(-vinyl pyridine), polyacrylamides, e.g. poly(N-isopropylacrylamide), poly(amido-amines), poly(ethylene imine), poly(ethylene oxide-block-propylene oxide), poly(ethylene oxide-block-propylene oxide-block-ethylene oxide), poly(styrene-block-isobutylene-block-styrene), poly(hydroxystyrene-block-isobutylene-block-hydroxystyrene), polydialkylsiloxanes, polysaccharides, polyacrylates and polyalkylmethacrylates, e.g. polymethylmethacrylate and poly(2-hydroxyethylmethacrylate) and wherein said microparticles comprise a material selected from the group consisting of polyesters, e.g. poly(lactic acid), poly(lactic-co-glycol acid), poly(glycolic acid), poly(3-hydroxybutyrate), poly(3-hydroxyvalerate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and polycaprolactone, polyamides, polysaccharides, polyurethanes, polyalkylmethacrylates and polyacrylates, e.g. polymethylmethacrylate and poly(2-hydroxyethylmethacrylate) and wherein the microparticles comprise a pharmaceutically active compound.

## Claims

### Claim 1

A catheter balloon comprising a flexible coating on its outer surface wherein the flexible coating is associated with a plurality of microparticles
wherein the flexible coating comprises a material selected from the group consisting of poly(N-vinyl-pirrolidone), poly(N-vinyl-pirrolidone-co-butylacrylate), poly(4-vinyl pyridine), polyacrylamides, poly(N-isopropylacrylamide), poly(amido-amines), poly(ethylene imine), poly(ethylene oxide-block-propylene oxide), poly(ethylene oxide-block-propylene oxide-block-ethylene oxide), poly(styrene-block-isobutylene-block-styrene), poly(hydroxystyrene-block-isobutylene-block-hydroxystyrene), polydialkylsiloxanes, polysaccharides, polyacrylates, polyalkylmethacrylates, polymethylmethacrylate, and poly(2-hydroxyethylmethacrylate);
wherein the microparticles comprise a material selected from the group consisting of polyesters, poly(lactic acid), poly(lactic-co-glycol acid), poly(glycolic acid), poly(3-hydroxybutyrate), poly(3-hydroxyvalerate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate), polycaprolactone, polyamides, polysaccharides, polyurethanes, polyalkylmethacrylates, polyacrylates, polymethylmethacrylate, and poly(2-hydroxyethylmethacrylate); and
wherein the microparticles further comprise a pharmaceutically active compound.

### Claim 2 (depends on 1)

The catheter balloon of claim 1, wherein the microparticles do not release pharmaceutically active compound upon inflation of the catheter balloon, but release pharmaceutically active compound when the inflating catheter balloon presses against the wall of a blood vessel.

### Claim 3 (depends on 1)

The catheter balloon of claim 1, wherein the microparticles comprise poly(lactic acid) or polycaprolactone.

### Claim 4 (depends on 3)

The catheter balloon of claim 3, wherein the microparticles comprise poly(lactic acid) and triacetin.

### Claim 5 (depends on 3)

The catheter balloon of claim 3, wherein the microparticles are prepared in the presence of camphor and ammonium carbonate.

### Claim 6 (depends on 1)

The catheter balloon of claim 1, wherein the microparticles comprise micelles.

### Claim 7 (depends on 6)

The catheter balloon of claim 6, wherein the micelles comprise the pharmaceutically active compound.

### Claim 8 (depends on 7)

The catheter balloon of claim 7, wherein the micelles comprise D-α-tocopherol poly(ethylene glycol) 1000 succinate.

### Claim 9 (depends on 1)

A method for delivering a pharmaceutically active compound to a predetermined target in a blood vessel, the method comprising:
inserting the catheter balloon of claim 1 into a subject in need of therapy with the pharmaceutically active compound,
monitoring whether the catheter balloon has reached the predetermined target, and
inflating the catheter balloon, thereby releasing the pharmaceutically active compound.
